Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Clinical trial NCT01072357 · COMPLETED
Trial details
- NCT number
- NCT01072357
- Sponsor
- Reza Dana, MD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2015-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.